Product code PHX— Orthopedic

AEQUALIS REVERSED SHOULDER PROSTHESIS

Classification name
Shoulder Prosthesis, Reverse Configuration
Device class
Class 2
Regulation
21 CFR 888.3660
Advisory panel
Orthopedic
Total cleared
205
First cleared
Most recent

FDA classification definition

“Intended to be used to relieve pain and to replace the glenoid and humeral side of the shoulder joint in order to restore mobility in a grossly rotator cuff deficient joint with severe arthropathy or a previous joint replacement with a grossly rotator cuff deficient joint.”

— U.S. Food and Drug Administration, device classification record for product code PHX under 21 CFR 888.3660, via openFDA

Market context for product code PHX

FDA has cleared 205 devices under product code PHX between 2003 and 2026, filed by 43 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

last 15 years

Top applicants under product code PHX

Adverse events under product code PHX

product code PHX
Death
10
Injury
9,705
Malfunction
1,252
Total
10,967

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recent clearances under product code PHX

1–100 of 205

Data sourced from openFDA. This site is unofficial and independent of the FDA.